New injection could ease pain after belly surgery
NCT ID NCT07491146
First seen Mar 25, 2026 · Last updated Jun 22, 2026 · Updated 13 times
Summary
This study tests a new drug called HSK55718 for pain after abdominal surgery. About 200 adults will receive either the drug, a placebo, or an active comparator. The goal is to see if it reduces pain over 24 hours and to check its safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN AFTER ABDOMINAL SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sichuan Provincial People's Hospital
Sichuan, China
-
The Third Xiangya Hospital of Central South University, Changsha, hunan
Changsha, Hunan, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HSK55718 injection
What this could lead to
If successful, this could provide a new painkiller option for people recovering from abdominal surgery, potentially with fewer side effects than current treatments.
What could go wrong
This is an early Phase 2 trial with only 200 participants. It may not show clear benefit or could have unexpected side effects. Results may not apply to all types of surgery.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.